Category: Antibody Technologies
Australia Antibody Technologies
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
Australia & New Zealand Research Antibodies Market Size, Share & Trends Analysis Report By Product, By Specificity, By Technology, By Source, By Application, By End Use, By Country, And Segment Forecasts, 2024 - 2030
... & New Zealand Research Antibodies Market Growth & Trends The Australia & New Zealand research antibodies market size is expected to reach USD 77.6 million by 2030, registering a CAGR of 4.8% from 2024 to ... Read More
-
Asia-Pacific Protein a Resin Market By Product Type (Agarose-based, Glass/Silica-based, Organic Polymer-based); By Type (Recombinant, Natural); By Application (Antibody Purification, Immunoprecipitation); By End User (Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes, Others); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 Asia-Pacific Protein A Resin Market Size Booming at 9.5% CAGR to Cross USD ... Read More
Research Assistance
